王伽伯，男，1981年1月出生，毕业于成都中医药大学。博士，教授，山西中医药大学硕士生导师，首都医科大学中医药学院院长。先后主持科研项目12项，发表论文300余篇，其中SCI论文150余篇，出版专著5部。

研究学科（领域）：临床中药学

研究方向：中药药理与创新药研究

科研项目：

1.中药药理学，国家中医药管理局高水平中医药重点学科建设项目（ZYYZDXK-2023004），国家中医药管理局，2023.9-2026.12，600万，主持

2.中药药理学，青年岐黄学者培养项目，国家中医药管理局，2023.09-2026.12，60万，主持

3.基于通腑泄热的大黄治疗重症酒精性肝炎的物质基础和作用机制研究（U21A20412），国家自然科学基金重点项目，国家自然科学基金委，2022.01-2025.12，260万，主持

代表性成果：

1.Dan Gao, Wei-wei Yi, Bo Liu, Cong-en Zhang, Cui-cui Yang, Li Zeng, Lin Li, Guangbin Luo*, Lan Zhang*, Zhen-yu Ju*, Jia-bo Wang*. Tetrahydroxy stilbene glucoside rejuvenates aging hematopoietic stem cells with predilection for lymphoid differentiation via AMPK and Tet2. Journal of Advanced Research, 2024; https://doi.org/10.1016/j.jare.2024.04.027

2.Zhi-Tao Ma, Zhuo Shi, Xiao-He Xiao*, Jia-Bo Wang*. New Insights into Herb-Induced Liver Injury. Antioxidants & Redox Signaling, 2023; 38(16-18): 1138-1149

3.Wenjuan Wu, Ying Li, Pengyue Song, Qingbin Xu, Nan Long, Peng Li, Lidong Zhou, Bin Fu, Jiabo Wang*, Weijun Kong*. Metal-organic framework (MOF)-based sensors for exogenous contaminants in food: Mechanisms, advances, and prospects. Trends in Food Science & Technology, 2023; 138: 238–271

4.Jiabo Wang#, Haibo Song#, Feilin Ge#, Peng Xiong, Jing Jing, Tingting He, Yuming Guo, Zhuo Shi, Chao Zhou, Zixin Han, Yanzhong Han, Ming Niu, Zhaofang Bai, Guangbin Luo, Chuanyong Shen*, Xiaohe Xiao*. Landscape of DILI-related adverse drug reaction in China Mainland. Acta Pharmaceutica Sinica B, 2022;12(12):4424-4431

5.Yuan Gao, Jia-bo Wang*. Invited Commentary: Indirect action pattern: A remote and cross-organ pharmacological mechanism for drug innovation. Acta Pharmaceutica Sinica B, 2022; 12(8): 3448-3450

6.Jia- Bo Wang#, Ang Huang#, Yijin Wang#, Dong Ji#, Qing- Sheng Liang, Jun Zhao, Guangde Zhou, Shuhong Liu, Ming Niu, Ying Sun, Hui Tian, Guang-Ju Teng, Bin- Xia Chang, Jing- Feng Bi, Xiao- Xia Peng, Shaojie Xin, Huan Xie, Xiong Ma, Yi-Min Mao, Suthat Liangpunsakul, Romil Saxena, Guruprasad P. Aithal*, Xiao-He Xiao*, Jingmin Zhao*, Zhengsheng Zou*. Corticosteroid plus glycyrrhizin therapy for chronic drug- or herb-induced liver injury achieves biochemical and histological improvements: a randomised open-label trial. Alimentary Pharmacology & Therapeutics, 2022;55(10): 1297- 1310

7.Le Zhang, Ming Niu, Ai-wu Wei, Jin-fa Tang, Peng-yan Li, Di Song, Zhao-fang Bai, You-ping Liu, Xiao-he Xiao, Jia-bo Wang*. Clinical correlation between serum cytokines and the susceptibility to Polygonum multiflorum induced liver injury and an experimental study. Food & Function, 2022, 13: 825–833

8.Tu, Can; Niu, Ming; Wei, Ai-Wu; Tang, Jin-Fa; Zhang, Le; Jing, Jing; Xiao, Xiao-He*; Wang, Jia-Bo*. Susceptibility-Related Cytokine Panel for Prediction of Polygonum multiflorum-Induced Hepatotoxicity in Humans. Journal of Inflammation Research, 2021, 14: 645-655

8.Zhang Le; Niu Ming; Wei Ai-wu; Tang Jin-fa; Tu Can; Bai Zhao-fang; Zou Zhengsheng; Xiao Xiao-he*; Liu You-ping*; Wang Jiabo*. Risk profiling using metabolomic characteristics for susceptible individuals of drug-induced liver injury caused by Polygonum multiflorum. Archives of Toxicology, 2020, 94(1): 245-256

10.Jia Tong; Jingjing Gao; Qingzhen Liu; Chenyang He; Xing Zhao; Yawei Qi; Tiangang Yuan; Pengyan Li; Ming Niu; Dongyao Wang; Le Zhang; Weiyong Li; Jiabo Wang*; Zhongjian Zhang*; Shiyong Peng*. Resveratrol derivative excited postsynaptic potentiation specifically via PKCβ-NMDA receptor mediation. Pharmacological Research, 2020, 152: 104618

11.Chaopeng Li#; Tai Rao#; Xiaoping Chen; Zhengsheng Zou; Aiwu Wei; Jinfa Tang; Peng Xiong; Pengyan Li; Jing Jing; Tingting He; Zhaofang Bai; Jiye Yin; Zhirong Tan; Peng Yu; Honghao Zhou; Jiabo Wang*; Xiaohe Xiao*; Dongsheng Ouyang*. HLA-B*35:01 Allele Is a Potential Biomarker for Predicting Polygonum multiflorum-Induced Liver Injury in Humans. Hepatology, 2019, 70(1): 346-357

12.中药质量生物评价，共同主编，2018，人民卫生出版社，749千字

13.中药材商品规格标准化研究，副主编，2016，人民卫生出版社，749千字

14.中药药性寒热差异的生物学表征，副主编，2010，科学出版社，432千字

15.临床中药创新及实践：衷中参西 医药圆融，副主编，2023，科学出版社

16.中药品质评价方法指南，共同负责人，2017，中华中医药学会团体标准

17.何首乌安全用药指南，共同负责人，2019，中华中医药学会团体标准

18.中药药源性肝损伤临床评价技术指导原则，主要执笔人，2018，国家药监局技术指导原则

联系方式：

办公电话：010-83911623

Email：jiabo_wang@ccmu.edu.cn